Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Total mesorectal excision (TME) has become the contemporary standard of treatment for patients with rectal cancer. The
multidisciplinary approach to colorectal cancer ensures appropriate treatment for each patient with rectal cancer. Pathologists
play an important role in the evaluation of these specimens, including the quality assurance of surgical performance and evaluation
of the circumferential radial margin (CRM). The most significant predictor of local recurrence and quality of the excised mesorectum
is another important factor in assessing the risk of local recurrence in patients with a negative CRM. Proper pathological assessment
of the TME specimen provides important prognostic information, as well as critical feedback to surgeons regarding technical
performance. So, high quality histopathological reporting is necessary in the management of rectal cancer. In 2014, we began to
perform pathological reports of rectal cancer according to guidelines of Royal College of Pathologists. Our reports conclude points
such as site of the tumor, diameter of the tumor, distance of tumor to resection margin, histological type, degree of differentiation,
TNM staging, total number of lymph nodes, isolated apical lymph node metastasis, presence/absence of lymph node metastasis,
depth of invasion, neural invasion within tumor, vascular or lymphatic invasion within tumor, resection margin, presence/absence
of perforation, involvement of circumferential margin, relationship of tumor to peritoneal reflection and effects of neoadjuvant
therapy. Routine pathological report should be adequate and it remains the main arbiter of management, prognosis, surgical quality
assessment and gives us an opportunity to compare the results.